Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
PSMA PET/CT-Derived Indicators and Outcomes After [177Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 06, 2025
Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [18F]DCFPyL PSMA imaging.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 08, 2025
DNA-damage dependent isoform switching modulates RIF1 DNA repair complex assembly and phase separation.
Journal: The Journal of biological chemistry
Published: May 30, 2025
Race and Outcomes to [177Lu]Lu-PSMA-617 in Advanced Prostate Cancer.
Journal: Cancers
Published: April 29, 2025
[68Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 22, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma.
Journal: Scientific reports
Published: March 15, 2025
Rethinking Radiology Research Residencies.
Journal: Journal of the American College of Radiology : JACR
Published: February 23, 2025
Altering translation allows E. coli to overcome G-quadruplex stabilizers.
Journal: Nucleic acids research
Published: December 12, 2024
DNA-damage dependent isoform switching modulates RIF1 DNA repair complex assembly and phase separation.
Journal: bioRxiv : the preprint server for biology
Published: November 18, 2024
Altering translation allows E. coli to overcome chemically stabilized G-quadruplexes.
Journal: bioRxiv : the preprint server for biology
Published: August 26, 2024
PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy.
Journal: Cancer journal (Sudbury, Mass.)
Published: May 16, 2024
Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 19, 2024
Last Updated: 09/26/2026